Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solidarity Trial Philippines: Additional Treatments for COVID-19
NCT05024006Phase 3Completed
- Sponsor
- University of the Philippines
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands, Cytokines & Interferons, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of remdesivir, hydroxychloroquine, lopinavir + ritonavir, interferon beta-1a, acalabrutinib tablet (Variant 1) in coronavirus disease 2019 (COVID-19), sponsored by University of the Philippines. Started Apr 2020; status: completed.
02
Drugs
remdesivirhydroxychloroquinelopinavir + ritonavirinterferon beta-1aacalabrutinib tablet (Variant 1)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05024006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05024006.